InterCure Ltd.
INCRNASDAQHealthcareDrug Manufacturers - Specialty & Generic
As of Oct 27, 2026 close
- Market cap
- $45.31M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.68$6.15
- Volume (live)
- -
- Avg. volume (3M)
- 4.34K
InterCure (INCR) Stock Price & Financial Analysis
InterCure Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $4.44 - $4.49 |
|---|---|
| 52-Week High | $6.15 |
| 52-Week Low | $0.68 |
| Open | $4.49 |
| Volume (last close) | 1.82K |
| Average Volume (3M) | 4.34K |
| Revenue (TTM) | 86.63M |
|---|---|
| Net Income (TTM) | -11.45M |
| Free Cash Flow (TTM) | 4.26M |
| EPS (TTM) | −$1.07 |
| Profit Margin | -13.22% |
| Operating Margin | -10.08% |
| Return on Equity (ROE) | -9.01% |
| Debt to Equity | 0.18 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 45.31M |
|---|---|
| Shares Outstanding | 10.14M |
| Price to Sales (P/S) | 0.52 |
| Price to Book (P/B) | 0.36 |
| EV/EBITDA | -2.97 |
| 50-Day MA | $5.15 |
|---|---|
| 200-Day MA | $2.98 |
| 1-Year Change | +202.04% |
Source: Market prices and company fundamentals. Data as of Oct 27, 2026. Data sources and methodology
InterCure at a Glance
As of the Oct 27, 2026 close, InterCure (INCR) has a market capitalization of $45.31M. The stock trades at 0.5× sales. Over the trailing twelve months it lost $11.45M on revenue of $86.63M and generated $4.26M of free cash flow. Revenue grew 13.1% year over year.
As of its latest reported balance sheet, it holds $14.90M in cash and securities against $22.59M of debt, a net debt position of $7.69M.
InterCure does not currently pay a dividend.
The share price is up 202.0% over the past year. At $4.47 (the Oct 27, 2026 close) it sits within its 52-week range of $0.68 to $6.15, above its 200-day moving average of $2.98.
Frequently Asked Questions About InterCure
What is the current stock price for INCR?
As of the Oct 27, 2026 close, INCR stock trades at $4.47. The 52-week range is $0.68–$6.15, with a day range of $4.44–$4.49.
What is the P/E ratio for INCR?
The P/E ratio (Price-to-Earnings) for INCR is shown in the Key Statistics section. This valuation metric helps compare InterCure Ltd. to industry peers.
Does INCR pay dividends?
InterCure does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for INCR?
Analyst ratings and recommendations for INCR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of INCR?
As of the Oct 27, 2026 close, InterCure's market capitalization is $45.3M, classifying it as a micro-cap company. InterCure operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.